Sjöstedt, Noora
44  results:
Search for persons X
?
3

In vitro identification of decreased function phenotype ABC..:

Suominen, Laura ; Sjöstedt, Noora ; Vellonen, Kati-Sisko...
European Journal of Pharmaceutical Sciences.  188 (2023)  - p. 106527 , 2023
 
?
4

Novel inhibitors of breast cancer resistance protein (BCRP,..:

Deng, Feng ; Sjöstedt, Noora ; Santo, Mariangela...
European Journal of Pharmaceutical Sciences.  181 (2023)  - p. 106362 , 2023
 
?
5

Considerations for Physiologically Based Modeling in Liver ..:

Murphy, William A. ; Adiwidjaja, Jeffry ; Sjöstedt, Noora...
Clinical Pharmacology & Therapeutics.  113 (2022)  2 - p. 275-297 , 2022
 
?
6

Functional in vitro characterization of SLCO1B1 variants an..:

Kiander, Wilma ; Sjöstedt, Noora ; Manninen, Riikka...
European Journal of Pharmaceutical Sciences.  176 (2022)  - p. 106246 , 2022
 
?
7

Effect of Carbidopa Dose on Levodopa Pharmacokinetics With ..:

Tuunainen, Johanna ; Sjöstedt, Noora ; Vahteristo, Mikko...
European Journal of Drug Metabolism and Pharmacokinetics.  48 (2022)  1 - p. 23-34 , 2022
 
?
8

Regulation of Drug Transport Proteins—From Mechanisms to Cl..:

Brouwer, Kim L.R. ; Evers, Raymond ; Hayden, Elizabeth...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 461-484 , 2022
 
?
 
?
12

Efflux transport of nicotine, cotinine and trans‐3′‐hydroxy..:

Järvinen, Erkka ; Sjöstedt, Noora ; Koenderink, Jan B...
Basic & Clinical Pharmacology & Toxicology.  125 (2019)  6 - p. 490-498 , 2019
 
?
13

Endogenous, cholesterol-activated ATP-dependent transport i..:

Sjöstedt, Noora ; Salminen, Tiina A. ; Kidron, Heidi
European Journal of Pharmaceutical Sciences.  137 (2019)  - p. 104963 , 2019
 
1-15